Aytu Biopharma (AYTU) Other Working Capital Changes (2014 - 2026)
Aytu Biopharma (AYTU) posted quarterly Other Working Capital Changes of -$165000.0 for Q1 2026, down 236.73% year-over-year from $120671.6 in Q1 2025, and up 9.34% quarter-over-quarter from -$182000.0 in Q4 2025.
Aytu Biopharma (AYTU) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Other Working Capital Changes for 7 consecutive years, with -$165000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 236.73% year-over-year to -$165000.0; the TTM figure through Mar 2026 stood at -$923000.0 (down 197.74% YoY), while the FY2025 annual figure was -$528000.0, up 86.11% from the prior year.
- Other Working Capital Changes rose to -$165000.0 in Q1 2026 per AYTU's latest filing, from -$182000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.8 million in Q4 2022 and bottomed at -$4.4 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged -$146000.0 across 5 years, with a median of -$484000.0 in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 13861.54% in 2023 and fell as far as 11245.45% in 2023.
- Aytu Biopharma's Other Working Capital Changes stood at $109000.0 in 2022, then slumped by 155.96% to -$61000.0 in 2023, then sank by 236.07% to -$205000.0 in 2024, then grew by 11.22% to -$182000.0 in 2025, then advanced by 9.34% to -$165000.0 in 2026.
- Business Quant data shows AYTU's Other Working Capital Changes at -$165000.0 in Q1 2026, -$182000.0 in Q4 2025, and -$403000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.03 Mn |
| Mar 31, 2026 | 2.03 Mn |
| Mar 31, 2026 | 2.03 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | -484,000.00 |
| Sep 30, 2025 | -484,000.00 |
| Sep 30, 2025 | -484,000.00 |
| Jun 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 798,000.00 |
| Dec 31, 2024 | 798,000.00 |
| Dec 31, 2024 | 798,000.00 |
| Sep 30, 2024 | -119,000.00 |
| Sep 30, 2024 | -119,000.00 |